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Introduction
Autoimmune diseases frequently affect women of
childbearing age. Gravidas with autoimmune diseases
have a tendency to develop complications, such as preg-
nancy-induced hypertension in pregnancies complicated
by systemic lupus erythematosus (SLE). The activity of
autoimmune diseases is often exacerbated during
pregnancy. The transplacental passage of autoantibodies
may have an effect on the fetus or neonate; congenital
heart block, in particular, is often irreversible. Therefore,
increased vigilance is required for pregnancies compli-
cated by autoimmune disorders.
Objectives
Herein the characteristics of newborns from mothers
with autoimmune disorders were evaluated.
Methods
Clinical manifestations were assessed in 40 newborn
infants from 38 mothers with autoimmune disororders
(20 with SLE, 10 with rheumatoid arthritis, 6 with anti-
phospholipid syndrome, 6 with Sjogren’s syndrome,
4 with screloderma, 1 with mixed connective tissue
disease, and 1 with juvenile dermatomyositis) who
attended the Tokyo Women’s Medical University Hospital
between January 2011 and November 2013. The following
information deriverd from the patients’ charts was
reviewed: maternal autoimmune disease, maternal autoan-
tibodies, medications prescribed during pregnancy, gesta-
tional age (GA), and autoantibodies transferred to the
infant.
Results
The average age of the mother at the time of the delivery
was 33.7 years. Twenty mothers had anti-Ro/SS-A, 5 had
anti-La/SS-B, and 4 had anti-RNP antibodies. Twenty-two
gravidas (57.9%) were treated with oral glucocorticoids
(GC) during pregnancy. The average dose of predoniso-
lone and methylprednisolone was 10.8 mg/day (2-30 mg/
day) and 8.0 mg/day (4-16 mg/day), respectively. Four
gravidas with SLE used immunosuppresants (cyclosporine
[n=2], tacrolimus [n=2]). Seven of 38 gravidas (18.7%)
were delivered by emergency cesarean section. The aver-
age GA at birth was 36 3/7 weeks (23 6/7-41 1/7 weeks)
and 17 of 40 (42.5%) had preterm births. Four of 23 term
newborns met the criteria for small for gestational age
(SGA). The average birth weight was 2314±649 g (range,
508-3676 g), and included 23 low birth weight (LBW)
newborns (57.5%) and 3 extremely LBW newborns (7.9%).
When the gravida used GC during pregnancy, there were
significantly higher rates of preterm births and SGA
neonates (p<0.05). The birth weights and GAs were not
significantly different between gravidas with and without
SLE. The average GA and birth weight of newborns whose
mothers were treated with GC was 35 5/7 weeks and 2131
±704 g, respectively, suggesting that GC may be a factor
that affects GA and birth weight. Autoantibodies were
detected in 18 infants (anti-Ro/SS-A [18/20; 90%] and
anti-La/SS-B [3/5; 80%]). One baby had congenital
complete heart block. Rash, thrombocytopenia, and hyper-
transaminasemia (ALT > 35 U/l) developed after hospital
discharge in 1, 3, and 4 infants, respectively. With respect
to neonates born to antiSS-A antibody-positive mothers,
maternal GC use or non-use had no effect on the inci-
dence of autoantibodies and infant symptoms. There were
no infants who developed congenital heart block born to
mothers who had used prednisolone during pregnancy.
Conclusion
The probabilities of preterm delivery and LBW infants
were higher and more remarkable in gravidas treated
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how maternal autoimmune disease activity influences the
fetus and neonate. Continued observation by pediatricians
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